DNA Methylation Profiling of MYC, SMAD2/3 and DNMT3A in Colorectal Cancer

Overview

Journal Oman Med J

Specialty General Medicine

Date 2021 Nov 22

PMID 34804598

Citations 6

Authors

Seyedeh Elham Norollahi

Maryam Gholamniya Foumani

Maryam Khoshbakht Pishkhan

Afshin Shafaghi

Majid Alipour

Vida Baloui Jamkhaneh

Mohammad Namayan Marghoob

Sogand Vahidi

Affiliations

Soon will be listed here.

Abstract

Epigenetic modifications, particularly DNA methylation, is commonplace and a remarkable factor in carcinogenesis transformation. Conspicuously, previous findings have presented a cluster of irregular promoter methylation alterations related with silencing of tumor suppressor genes, little is accepted regarding their sequential DNA methylation (hypo and hyper) modifications during the cancer progression. In this way, fluctuations of DNA methylation of many genes, especially MYC, SMAD2/3, and DNMT3A, have an impressive central key role in many different cancers, including colorectal cancer (CRC). CRC is distinguished by DNA methylation, which is related to tumorigenesis and also genomic instability. Importantly, molecular heterogeneity between multiple adenomas in different patients with CRC may show diverse developmental phenotypes for these kinds of tumors. Conclusively, studying factors that are involved in CRC carcinogenesis, especially the alterations in epigenetic elements, such as DNA methylation besides RNA remodeling, and histone modification, acetylation and phosphorylation, can be influential to find new therapeutic and diagnostic biomarkers in this type of malignancy. In this account, we discuss and address the potential significant methylated modifications of these genes and their importance during the development of CRC carcinogenesis.

Citing Articles

Unraveling the interplay of CD8 + T cells and microRNA signaling in cancer: implications for immune dysfunction and therapeutic approaches.

Zabeti Touchaei A, Vahidi S J Transl Med. 2024; 22(1):1131.

PMID: 39707465 PMC: 11662517. DOI: 10.1186/s12967-024-05963-5.

Mining and exploration of rehabilitation nursing targets for colorectal cancer.

Li R, He J, Ni Z, Zhang J, Chi X, Kang C Aging (Albany NY). 2024; 16(8):7022-7042.

PMID: 38637125 PMC: 11087124. DOI: 10.18632/aging.205739.

Pancreatic Neuroendocrine Tumors: Signaling Pathways and Epigenetic Regulation.

Saleh Z, Moccia M, Ladd Z, Joneja U, Li Y, Spitz F Int J Mol Sci. 2024; 25(2).

PMID: 38279330 PMC: 10816436. DOI: 10.3390/ijms25021331.

DNMT3A-mediated epigenetic silencing of SOX17 contributes to endothelial cell migration and fibroblast activation in wound healing.

Yu X, Ma X, Zhou J PLoS One. 2023; 18(10):e0292684.

PMID: 37856473 PMC: 10586696. DOI: 10.1371/journal.pone.0292684.

M2 Macrophage-Derived Exosomes Regulate miR-199a-3p Promoter Methylation Through the LINC00470-Mediated myc/DNMT3a Axis to Promote Breast Cancer Development.

Ma D, Wu J, Chen C, Niu Y, Ji K, Xiao Y Biochem Genet. 2023; 62(3):2082-2099.

PMID: 37851210 DOI: 10.1007/s10528-023-10531-5.

References

Yang T, Gao Y, Ma S, Wu Q, Li Z . Low-grade slightly elevated and polypoid colorectal adenomas display differential β-catenin-TCF/LEF activity, c-Myc, and cyclin D1 expression. World J Gastroenterol. 2017; 23(17):3066-3076. PMC: 5423043. DOI: 10.3748/wjg.v23.i17.3066. View

Jones P, Baylin S . The epigenomics of cancer. Cell. 2007; 128(4):683-92. PMC: 3894624. DOI: 10.1016/j.cell.2007.01.029. View

Xie F, Yuan Y, Xie L, Ran P, Xiang X, Huang Q . miRNA-320a inhibits tumor proliferation and invasion by targeting c-Myc in human hepatocellular carcinoma. Onco Targets Ther. 2017; 10:885-894. PMC: 5317304. DOI: 10.2147/OTT.S122992. View

Lin S, Raju G, Huff C, Ye Y, Gu J, Chen J . The somatic mutation landscape of premalignant colorectal adenoma. Gut. 2017; 67(7):1299-1305. PMC: 6031265. DOI: 10.1136/gutjnl-2016-313573. View

Suzuki M, Bird A . DNA methylation landscapes: provocative insights from epigenomics. Nat Rev Genet. 2008; 9(6):465-76. DOI: 10.1038/nrg2341. View

Freytag S . Enforced expression of the c-myc oncogene inhibits cell differentiation by precluding entry into a distinct predifferentiation state in G0/G1. Mol Cell Biol. 1988; 8(4):1614-24. PMC: 363321. DOI: 10.1128/mcb.8.4.1614-1624.1988. View

McCabe M, Lee E, Vertino P . A multifactorial signature of DNA sequence and polycomb binding predicts aberrant CpG island methylation. Cancer Res. 2009; 69(1):282-91. PMC: 2653261. DOI: 10.1158/0008-5472.CAN-08-3274. View

Belshaw N, Pal N, Tapp H, Dainty J, Lewis M, Williams M . Patterns of DNA methylation in individual colonic crypts reveal aging and cancer-related field defects in the morphologically normal mucosa. Carcinogenesis. 2010; 31(6):1158-63. DOI: 10.1093/carcin/bgq077. View

Vieira A, Fukumori C, Ferreira C . New insights into therapeutic strategies for gut microbiota modulation in inflammatory diseases. Clin Transl Immunology. 2016; 5(6):e87. PMC: 5067953. DOI: 10.1038/cti.2016.38. View

10.

Hellebrekers D, Griffioen A, van Engeland M . Dual targeting of epigenetic therapy in cancer. Biochim Biophys Acta. 2006; 1775(1):76-91. DOI: 10.1016/j.bbcan.2006.07.003. View

11.

Sameer A, Nissar S . Epigenetics in diagnosis of colorectal cancer. Mol Biol Res Commun. 2016; 5(1):49-57. PMC: 5019333. View

12.

Samadani A, Akhavan-Niaki H . Interaction of sonic hedgehog (SHH) pathway with cancer stem cell genes in gastric cancer. Med Oncol. 2015; 32(3):48. DOI: 10.1007/s12032-015-0492-3. View

13.

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014; 136(5):E359-86. DOI: 10.1002/ijc.29210. View

14.

Samadani A, Nikbakhsh N, Taheri H, Shafaee S, Fattahi S, Langroudi M . CDX1/2 and KLF5 Expression and Epigenetic Modulation of Sonic Hedgehog Signaling in Gastric Adenocarcinoma. Pathol Oncol Res. 2019; 25(3):1215-1222. DOI: 10.1007/s12253-019-00594-4. View

15.

Huang C, Liu H, Gong X, Wu L, Wen B . Expression of DNA methyltransferases and target microRNAs in human tissue samples related to sporadic colorectal cancer. Oncol Rep. 2016; 36(5):2705-2714. DOI: 10.3892/or.2016.5104. View

16.

Gaarenstroom T, Hill C . TGF-β signaling to chromatin: how Smads regulate transcription during self-renewal and differentiation. Semin Cell Dev Biol. 2014; 32:107-18. DOI: 10.1016/j.semcdb.2014.01.009. View

17.

Stopa M, Anhuf D, Terstegen L, Gatsios P, Gressner A, Dooley S . Participation of Smad2, Smad3, and Smad4 in transforming growth factor beta (TGF-beta)-induced activation of Smad7. THE TGF-beta response element of the promoter requires functional Smad binding element and E-box sequences for transcriptional.... J Biol Chem. 2000; 275(38):29308-17. DOI: 10.1074/jbc.M003282200. View

18.

Parang B, Kaz A, Barrett C, Short S, Ning W, Keating C . BVES regulates c-Myc stability via PP2A and suppresses colitis-induced tumourigenesis. Gut. 2017; 66(5):852-862. PMC: 5385850. DOI: 10.1136/gutjnl-2015-310255. View

19.

Ruan K, Fang X, Ouyang G . MicroRNAs: novel regulators in the hallmarks of human cancer. Cancer Lett. 2009; 285(2):116-26. DOI: 10.1016/j.canlet.2009.04.031. View

20.

Feinberg A, Tycko B . The history of cancer epigenetics. Nat Rev Cancer. 2004; 4(2):143-53. DOI: 10.1038/nrc1279. View